PUBLICATIONS · 11786570
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2002 Jan 15
- First author
- Goorin AM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Goorin AM
- type
- Author
- name
- Harris MB
- type
- Author
- name
- Bernstein M
- type
- Author
- name
- Ferguson W
- type
- Author
- name
- Devidas M
- type
- Author
- name
- Siegal GP
- type
- Author
- name
- Gebhardt MC
- type
- Author
- name
- Schwartz CL
- type
- Author
- name
- Link M
- type
- Author
- name
- Grier HE
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Goorin AM
- type
- Author
- name
- Harris MB
- type
- Author
- name
- Bernstein M
- type
- Author
- name
- Ferguson W
- type
- Author
- name
- Devidas M
- type
- Author
- name
- Siegal GP
- type
- Author
- name
- Gebhardt MC
- type
- Author
- name
- Schwartz CL
- type
- Author
- name
- Link M
- type
- Author
- name
- Grier HE
- type
- Author
- bibliography ids
- nci-bib-5c1280388e8fdadc7d943dbb
- book metadata
- content sha256
- f7371a5e55997ddbdd83588b3840b9f928f725774df4b9cf14f18960f9ad7e08
- document type
- citation
- dois
- 10.1200/JCO.2002.20.2.426
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:11786570
- immutable id
- pubmed:11786570@f7371a5e55997ddbdd83588b3840b9f928f725774df4b9cf14f18960f9ad7e08
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 2
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 426-33
- volume
- 20
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 11786570
- provenance
- batch id
- d4e82e28940c878dd0a2
- provider
- NCBI PubMed ESummary
- record sha256
- f75a16148a7c859584e06d4e301fdb885a52cc6de68274900c266c83b13f6032
- response sha256
- 257c7530b1505623f6712628a73c1e9b8b3119838f4ec701e62de2dab9d87468
- retrieved at
- 2026-09-09T23:45:44.017762+00:00
- publication date
- display
- 2002 Jan 15
- precision
- day
- year
- 2002
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Clinical Trial, Phase III
- Journal Article
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.
Preserved source evidence · Not medical advice
Triangle